Pharmaceutical Manufacturing Downtime: Causes, Risks and How to Reduce It
Updated: Nov 4

Pharmaceutical manufacturing downtime does not have the same impact on every system. A server interruption during general reporting may be manageable, while the same interruption during an active production batch can delay operations, trigger additional quality review and affect the records needed to show the process remained controlled.
What Causes Pharmaceutical Manufacturing Downtime?
Computerized systems supporting pharmaceutical operations can become unavailable because of:
Server, storage or power failures
Operating system or application faults
Network or communication failures
Failed patches, upgrades or configuration changes
Planned maintenance that requires a system shutdown
Failure of an external interface or dependent service
The impact depends on which workload is affected. An interruption to a reporting system does not carry the same consequence as one to a system supporting an active batch, electronic production records or centralized environmental monitoring.
When a Short Interruption Can Still Be Too Long
If a server supporting batch execution, electronic production records or centralized environmental monitoring becomes unavailable during production, the consequences may include:
A production hold while records and process conditions are verified
Manual reconciliation of interrupted or missing records
Deviation investigation and additional quality review
Delayed batch completion or release, or rework and batch loss where process integrity cannot be demonstrated
An interruption does not automatically make a batch unusable, but restoring the server is only the first step.
High Availability restores a workload by failing over to a standby environment. That is acceptable for many business systems, but the recovery window may not be for workloads supporting an active critical process. The question is not only how fast the server recovers, but whether the process can tolerate the interruption.
Where Fault Tolerance Fits
Fault Tolerance is designed for supported server workloads that cannot accept a failover window. During a covered server or platform failure, it keeps the protected workload running rather than restarting it on a standby server. In pharmaceutical manufacturing, this may support selected workloads such as:
Manufacturing Execution Systems during active production: keeping batch execution functions and operator instructions available through the covered failure
Electronic batch or production record systems: maintaining access to the protected application and the records it holds, reducing the need for recovery and reconciliation caused by a server interruption
Centralized environmental monitoring and alarm systems: maintaining the protected monitoring application and its available records while local controllers continue operating equipment independently
Laboratory Information Management Systems for time-sensitive testing: maintaining access to testing and review workflows during the covered failure
Where the affected server workload is the cause of the interruption, FT can reduce the likelihood of an immediate production hold, record recovery or additional deviation review.
FT addresses covered server or platform failures. It does not by itself protect production equipment, PLCs, sensors, network paths, external interfaces or application-level faults. These dependencies require separate controls.
Continuity Must Be Documented and Tested
PIC/S GMP Annex 11, clause 16 states that computerized systems supporting critical processes should have continuity provisions for system breakdowns. The time required to bring the alternative arrangement into use should be based on risk, and the continuity arrangement should be documented and tested.
FT can form part of that design, but teams still need to define what it covers, test how the application behaves during a failure, plan for failures outside its scope, and retest after major platform or application changes. FT supports availability; it does not by itself establish GMP compliance.
Not every pharmaceutical application needs Fault Tolerance. Where a short recovery window is acceptable, High Availability may be enough. Where a supported workload must stay available through a covered server or platform failure, Fault Tolerance is designed to avoid the failover window.




